Immediate Impact

5 by Nobel laureates 11 from Science/Nature 54 hit
Sub-graph 1 of 23

Citing Papers

Osteoarthritis
2025 Hit
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
2025 Hit
2 intermediate papers

Works of Erik Lindström being referenced

The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis
2018
Proteolytic activation of the epithelial sodium channel (ENaC) by the cysteine protease cathepsin-S
2012
and 2 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Erik Lindström 347 322 251 237 213 63 1.2k
Harald Schwörer 339 1.0× 273 0.8× 401 1.6× 336 1.4× 392 1.8× 58 1.4k
Jeremy D. Gale 287 0.8× 319 1.0× 246 1.0× 348 1.5× 320 1.5× 51 1.4k
Raquel Guerrero‐Alba 207 0.6× 179 0.6× 142 0.6× 151 0.6× 190 0.9× 33 923
Daniela Renzi 376 1.1× 223 0.7× 439 1.7× 233 1.0× 238 1.1× 69 1.3k
Rakesh Kumar 399 1.1× 146 0.5× 107 0.4× 70 0.3× 163 0.8× 76 1.2k
Gabriele Barbanti 506 1.5× 331 1.0× 542 2.2× 134 0.6× 309 1.5× 55 1.4k
Amanda L. Lumsden 401 1.2× 263 0.8× 178 0.7× 123 0.5× 115 0.5× 42 1.1k
Dane D. Jensen 569 1.6× 257 0.8× 373 1.5× 98 0.4× 162 0.8× 36 1.3k
Gracious R. Ross 379 1.1× 178 0.6× 289 1.2× 90 0.4× 135 0.6× 49 1.0k
Jörg Glatzle 229 0.7× 291 0.9× 183 0.7× 303 1.3× 464 2.2× 53 1.4k

All Works

Loading papers...

Rankless by CCL
2026